Association between atopic diseases and venous thromboembolism: a case–control study in patients aged 45 years or less
Authors:
Open Access
- 1 April 2011
- journal article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 9 (4) , 870-873
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1Blood, 2010
- Plasma fibrin clot properties in atopic dermatitis: links between thrombosis and atopyJournal of Thrombosis and Thrombolysis, 2010
- Altered fibrin clot structure/function in patients with idiopathic venous thromboembolism and in their relativesBlood, 2009
- Platelets play important roles in the late phase of the immediate hypersensitivity reactionJournal of Allergy and Clinical Immunology, 2009
- Role of the coagulation system in allergic inflammation in the upper airwaysClinical Immunology, 2008
- Past and future of genetic research in thrombosisJournal of Thrombosis and Haemostasis, 2007
- Tissue factor pathway inhibitor is highly susceptible to chymase‐mediated proteolysisThe FEBS Journal, 2007
- The −675 4G/5G plasminogen activator inhibitor‐1 promoter polymorphism in house dust mite‐sensitive allergic asthma patientsAllergy, 2006
- C5a stimulates production of plasminogen activator inhibitor-1 in human mast cells and basophilsBlood, 2002
- Thrombin-Activatable Fibrinolysis Inhibitor Deficiency in Cirrhosis Is Not Associated With Increased Plasma FibrinolysisGastroenterology, 2001